Detalles de la búsqueda
1.
First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 25(6): 744-759, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38821083
2.
Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial.
Lancet Oncol
; 23(6): 818-828, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35654052
3.
Effect of ruxolitinib on the oral mucosa of patients with steroid-refractory chronic Graft-versus-Host disease and oral involvement.
Clin Oral Investig
; 26(5): 4209-4216, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35169886
4.
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.
Blood
; 134(14): 1132-1143, 2019 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31292114
5.
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center study.
Haematologica
; 106(1): 87-97, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31974198
6.
Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Haematologica
; 109(5): 1608-1613, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38205539
7.
Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia.
Blood
; 137(8): 1117-1120, 2021 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33027809
8.
Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications.
J Antimicrob Chemother
; 69(3): 809-14, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24123431
9.
Improved Outcome of Allogeneic Transplantation in Older Patients Treated for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Reduced Duration of Immune Suppression.
Transplant Cell Ther
; 2024 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38740138
10.
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling.
Cancer Med
; 13(9): e6756, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38680089
11.
Allogeneic Stem Cell Transplantation in Patients >40 Years of Age With Acute Lymphoblastic Leukemia: Reduced Intensity Versus Myeloablative Conditioning.
Transplantation
; 107(12): 2561-2567, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37389645
12.
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY.
EClinicalMedicine
; 65: 102307, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38033506
13.
Long Axial Field-of-View PET for Ultra-Low-Dose Imaging of Non-Hodgkin Lymphoma during Pregnancy.
Diagnostics (Basel)
; 13(1)2022 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36611320
14.
miR-181a is a novel player in the STAT3-mediated survival network of TCRαß+ CD8+ T large granular lymphocyte leukemia.
Leukemia
; 36(4): 983-993, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34873301
15.
Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working group.
Leuk Lymphoma
; 63(10): 2276-2289, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35737364
16.
Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial.
Blood Adv
; 6(4): 1115-1125, 2022 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34883506
17.
Risk factors associated with the development of moderate to severe chronic graft-versus-host disease after non-myeloablative conditioning allogeneic stem cell transplantation in patients with AML or MDS.
Hum Cell
; 33(1): 243-251, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31732859
18.
Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study.
Exp Hematol
; 89: 55-60.e6, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32781097
19.
Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study.
Lancet Haematol
; 6(11): e551-e561, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31564649
20.
Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study.
Blood Adv
; 8(4): 842-845, 2024 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38190628